Registry of Etanercept (Enbrel®) In Children with Juvenile Rheumatoid Arthritis

Sponsor ID

20021626

Clinicaltrials.gov ID

NCT00078793

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

This study will evaluate long-term safety of etanercept with or without other DMARDs in children with polyarticular course or systemic juvenile rheumatoid arthritis (JRA) compared to a cohort of subjects with polyarticular or systemic JRA receiving methotrexate with or without other DMARDs.

Additional Study Details

Phase

N/A

Product

etanercept

Type

Observational

Masking

N/A

Enrollment

600

Additional Study Details

Protocol Summary

Primary Outcome Measures

Adverse event rates and severity

Timeframe: 36 months of observation

Secondary Outcome Measures

Growth data and Tanner scores

Timeframe: 36 months of observation

Study Documents

Study Synopsis

Available Language(s): English

Download Document(s)

Locations

No locations found.